Helicobacter Infections: all 188 studies

Page 1 of 2. Open to participants first (33), then studies with results posted, then the rest; newest registration first within each.

• The Prevalence and the Pathophysiological Role of Non-Helicobacter Pylori Helicobacter Spp. in Well-defined Gastric Diseases and (Pre-) MalignanciesRecruitingNCT07770126
• Efficacy Comparison of 10-Day High-Dose Versus 14-Day Standard-Dose Vonoprazan Plus Amoxicillin in Helicobacter Pylori Eradication: A Multicenter Non-Inferiority Randomized Controlled TrialNot yet recruitingNCT07720037Phase 4
• Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Pylori InfectionRecruitingNCT07293910Phase 2
• Clinical Trial to Evaluate the Efficacy of Probit-Based Triple Therapy for Helicobacter Pylori EradicationNot yet recruitingNCT07115173Phase 4
• Comparison of Two Treatment Regimens of Helicobacter Pylori InfectionNot yet recruitingNCT07021729Phase 4
• The Effect of Vitamin D Supplement as Adjuvant Therapy in Eradication of Helicobacter Pylori InfectionNot yet recruitingNCT06964334Phase 3
• An Observational Study for Gastric Cancer in Carriers of High Risk Helicobacter PyloriRecruitingNCT06896370
• Low-Dose Amoxicillin Dual-Therapy Combined with Licorice and Lotus Root Powder Helicobacter Pylori TreatmentNot yet recruitingNCT06881524Not applicable
• Impact of Helicobacter Pylori Infection on Prolactin Levels in Reproductive-Age Women to Determine Whether H. Pylori Infection is Associated with Elevated Prolactin Levels and Assess the Clinical ImplicationsNot yet recruitingNCT06870773
• The Efficacy and Safety of Keverprazan for Helicobacter Pylori EradicationNot yet recruitingNCT06777732Early Phase 1
• Efficacy of a 14-Day Bismuth-Containing Quadruple Therapy Guided by Drug Susceptibility Testing in Patients with Extremely Refractory Helicobacter Pylori Infection: an Exploratory StudyNot yet recruitingNCT06731023
• Knowledge, and Practice of Helicobacter Pylori InfectionNot yet recruitingNCT06628089
• The Efficacy of Quadruple Therapy Containing Sodium Bicarbonate as the Primary Treatment for Helicobacter Pylori InfectionNot yet recruitingNCT06591494Phase 2/3
• H-pylori Infection With Disease Activity in Systemic Lupus Erythematosus and Rheumatoid ArthritisNot yet recruitingNCT06586567
• Efficacy and Safety of Bismuth Quadruple Therapy Containing Cefuroxime and Tetracycline as First-line Therapy for Eradicating Helicobacter Pylori in Patients Allergic to PenicillinNot yet recruitingNCT06351891Phase 4
• Diagnostic Performance of CIM for Helicobacter Pylori Infection in Patients With Peptic Ulcer BleedingNot yet recruitingNCT06273384
• Feasibility Study of the Proposed Test-and-treat Screening Program in Younger Participants With H. Pylori InfectionEnrolling by invitationNCT06216639
• Tailored Vs. Empirical Helicobacter Pylori Infection TreatmentNot yet recruitingNCT06200779Phase 4
• Bismuth Quadruple Therapy Versus Standard Triple TherapyRecruitingNCT06143124Phase 4
• Levofloxacin Concomitant Versus Levofloxacin SequentialNot yet recruitingNCT06065267Phase 4
• Efficacy of Low-dose Vonoprazan for Helicobacter Pylori EradicationNot yet recruitingNCT06037122
• Frequency of h.Pylori in Children With Dyspeptic SymptomsNot yet recruitingNCT05951998
• Comparison of Two Dual Therapies in the First-line Treatment of Helicobacter Pylori Infection （SHARE2301）RecruitingNCT05870683Not applicable
• Prevalence and Risk Factors of Helicobacter Pylori Infection in Children and Young AdultsRecruitingNCT05830357
• Epidemiology of Helicobacter Pylori Infection in MoscowRecruitingNCT05775120
• Vonoprazan-containing Triple Therapy Versus Empiric Bismuth Quadruple Therapy for First-line Helicobacter Pylori Treatment: a Randomized Clinical TrialNot yet recruitingNCT05726734Phase 4
• The Prevalence of Family-unit Helicobacter Pylori Infection in JiangsuRecruitingNCT05654857
• Fucoidan Assisted Eradication of Helicobacter PyloriRecruitingNCT05461508Phase 1/2
• Auto Fecal Microbial Transplant Post Helicobacter Pylori Antibiotic TherapyRecruitingNCT05329636Phase 1/2
• Prevalence and Trends of Antimicrobial Resistance of Helicobacter Pylori in KoreaRecruitingNCT05247112
• Pathogen-microbiome Interaction During Helicobacter Pylori InfectionRecruitingNCT05121025
• A Comparison of Four Different Treatment Regimens of Helicobacter Pylori in Chinese ChildrenRecruitingNCT03365609Not applicable
• The Efficacy of the 7 Days Tailored Therapy as the 1st Eradication of H. Pylori InfectionRecruitingNCT02373280Not applicable
• A Phase 1 Study to Evaluate PK Profile of Multiple Oral Administrations of TNP-2092 Capsules in Healthy SubjectsCompletedNCT06190340Phase 1Results posted
• Efficacy and Safety After Multiple Doses of TNP-2198 Capsules, Rabeprazole Sodium Enteric-coated Tablets and Amoxicillin Capsules in Helicobacter Pylori Infected-positive ParticipantsCompletedNCT06076694Phase 2Results posted
• A Study to Evaluate Preliminary Helicobacter Pylori Eradication After Multiple Doses of TNP-2198 Capsules Combined With Rabeprazole Sodium Enteric-coated Tablets, or Rabeprazole Sodium Enteric-coated Tablets and Amoxicillin CapsulesCompletedNCT06076681Phase 1/2Results posted
• Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Helicobacter Pylori InfectionCompletedNCT04167670Phase 3Results posted
• Comparison Between Quadruple Regimens for Helicobacter Pylori Infection in EgyptCompletedNCT04039412Phase 4Results posted
• Comparison of Two Rescue Therapies for Helicobacter Pylori InfectionCompletedNCT02547012Not applicableResults posted
• Comparison of 12-day Reverse Hybrid Therapy and 12-day Standard Triple Therapy for Helicobacter Pylori InfectionCompletedNCT02359435Not applicableResults posted
• The Efficacy of the Tailored Therapy Based on Antimicrobial Susceptibility for 2nd Eradication of H. PyloriCompletedNCT02349685Not applicableResults posted
• Concomitant, Sequential, and Standard Triple Therapy for H. Pylori InfectionCompletedNCT01769365Phase 4Results posted
• Lactobacillus Reuteri in Management of Helicobacter Pylori Infection in Dyspeptic PatientsCompletedNCT01593592Not applicableResults posted
• Efficacy and Safety of an H.Pylori Vaccine in H.Pylori-Negative AdultsCompletedNCT00736476Phase 1Results posted
• Efficacy and Safety of Quadruple Therapy in Eradication of H. Pylori: A Comparison to Triple TherapyCompletedNCT00669955Phase 3Results posted
• Treating H. Pylori in Parkinson's Patients With Motor FluctuationsTerminatedNCT00664209Phase 3Results posted
• Comparison of Sequential or Concomitant Therapy for Helicobacter Pylori InfectionCompletedNCT00656968Phase 4Results posted
• Helicobacter Pylori Infection and Gastric Diseases in Lao PDR: First Community-Wide Population-Based StudyCompletedNCT07340593
• Treatment Adherence And Influencing Factors in Children With Helicobacter Pylori Infection During Eradication TherapyActive, not recruitingNCT06396780
• The Safety and Tolerability, Pharmacokinetics of TNP-2092 Capsules in Combination With Rabeprazole Sodium Enteric-coated TabletsCompletedNCT06337604Phase 1
• Clinical Efficacy and Safety Assessment of Alsareen Capsule for the Management of H. Pylori InfectionCompletedNCT06304532
• Esomeprazole/Vonoprazan Combined With High-dose Amoxicillin Dual Therapy for Primary Eradication of Helicobacter Pylori InfectionCompletedNCT06250634Not applicable
• A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of TNP-2198 Capsules in Asymptomatic Participants With Helicobacter Pylori InfectionCompletedNCT06081712Phase 1
• Helicobacter Pylori Prevalence in Southern Region of RomaniaCompletedNCT05874960
• Eradication of H. Pylori Infection With MoxifloxacinCompletedNCT05863858Phase 3
• Recurrence Rate Comparison Between Esomeprazole and Lansoprazole in Eradicating Helicobacter Pylori Infection Among ChildrenCompletedNCT05861687Phase 2/3
• Epidemiology of Helicobacter Pylori Infection in Children From SloveniaStatus unknownNCT05846061
• Stool Antigen In Diagnosis Of Helicobacter PyloriStatus unknownNCT05802732
• Clinical Utility of Upper Endoscopy in Diagnosis of Helicobacter Pylori InfectionStatus unknownNCT05787262Not applicable
• Helicobacter Pylori and Lacidophilin Tablets in Combination With Vonorazan Dual TherapyActive, not recruitingNCT05749081Phase 4
• Efficacy of Therapy Based on Fecal Molecular Antimicrobial Susceptibility Tests for Helicobacter Pylori InfectionStatus unknownNCT05718609Phase 4
• Effect of Probiotics on Eradication of Persistent H.Pylori InfectionStatus unknownNCT05674864Not applicable
• The Effect of Time Intervals for Rescue Treatment on Eradication Effect of Helicobacter Pylori InfectionStatus unknownNCT05620589
• Vonoprazan-based Therapy Versus Standard Regimen for Helicobacter Pylori Infection ManagementCompletedNCT05614934Phase 4
• A RCT of the Efficacy of Vonoprazan 20mg QD in the Treatment of Helicobacter Pylori InfectionStatus unknownNCT05590286Phase 4
• Eradication of Helicobacter Pylori With Bismuth Agent Quadruple and Traditional Chinese MedicineStatus unknownNCT05586464Phase 1
• The Efficacy of 10-day or 14-day Course of Bismuth-containing Quadruple Therapy:A Randomized Clinical TrialStatus unknownNCT05586113Phase 4
• Susceptibility-Guided Sequential Therapy for Helicobacter Pylori InfectionStatus unknownNCT05549115Not applicable
• A Clinical Trial on the Efficacy of Gastric Probiotics in the Treatment of Helicobacter Pylori InfectionStatus unknownNCT05483660Phase 2
• Influence of Oral Hp Infection and Oral Related Factors on Gastric Hp Infection and Eradication TherapyStatus unknownNCT05455372Not applicable
• 14-day Double Therapy Versus Bismuth Quadruple Therapy in First-line Treatment of Helicobacter Pylori InfectionStatus unknownNCT05438550Phase 4
• Helicobacter Pylori 23S rRNA/gyrA Gene Mutation Detection Kit (Fluorescence PCR Fusion Curve Method)CompletedNCT05410652
• Efficacy and Safety Study of Egg Yolk Antibody in Adjuvant Treatment of Helicobacter Pylori InfectionStatus unknownNCT05410223Not applicable
• The Effect of Lactobacillus Reuteri Probiotic as an Adjunct Treatment for Helicobacter Pylori Infection in AdultsCompletedNCT05399862Not applicable
• The Effects of Yogurt on Gut Microbiome and Metabolism in H. Pylori.CompletedNCT05374980Not applicable
• Qingre Huashi Granules Combined the Modified Dual Therapy for Helicobacter Pylori InfectionStatus unknownNCT05364619Not applicable
• Jinghua Weikang Capsule Containing Quadruple Therapy for IgAN With Helicobacter Pylori InfectionStatus unknownNCT05320133Not applicable
• Helicobacter Pylori Eradication Therapy for Epileptic ChildrenCompletedNCT05297695Phase 2/3
• Influencing Factors of Helicobacter Pylori Infection and Eradication FailureStatus unknownNCT05226819Not applicable
• Efficacy and Safety of 14-day Concomitant Therapy for Refractory Helicobacter Pylori InfectionStatus unknownNCT05133193Not applicable
• Efficacy and Safety of 14-day Concomitant Therapy for Difficult-to-Treat Helicobacter Pylori InfectionStatus unknownNCT05126121Not applicable
• Comparison Between High-dose Amoxicillin Dual Therapy and Pylera Quadruple Therapy in the Treatment of Helicobacter Pylori InfectionStatus unknownNCT05100446Early Phase 1
• Tetracycline Versus Doxycycline for HP Rescue TherapyStatus unknownNCT05018923Phase 4
• Efficacy and Safety of 14-day Concomitant Therapy for Helicobacter Pylori InfectionStatus unknownNCT04991584Not applicable
• Investigation on Diagnosis and Treatment of Helicobacter Pylori Infection by Gastroenterologists in Shandong ProvinceCompletedNCT04918134
• Helicobacter Pylori Infection Occurrence in RussiaCompletedNCT04892238
• Bismuth Quadruple Therapy With Cefuroxime for Helicobacter Pylori Eradication TreatmentSuspendedNCT04723472Not applicable
• The Relationship Between Helicobacter Pylori Infection and Inflammatory Bowel Diseases: A Real-life ObservationCompletedNCT04708405
• Efficacy of Tegoprazan Based Bismuth Quadruple Therapy for Helicobacter Pylori InfectionStatus unknownNCT04674774Not applicable
• Effectiveness of Rifabutin for Treatment of Helicobacter PyloriStatus unknownNCT04652284Phase 3
• The Prevalence of Helicobacter Pylori in Shanghai, 2013 to 2019CompletedNCT04636866
• Quadruple vs Tailored Therapy in the Treatment of Helicobacter Pylori InfectionCompletedNCT04621487Not applicable
• Intravenous Triple Therapy in the Treatment of Helicobacter Pylori Infection and Related Complications Caused by Active Peptic Ulcer DiseaseStatus unknownNCT04432233Phase 4
• Prospective Randomised Trial of First and Second Line Treatments of RCT of First and Second Line H Pylori Treatments in SloveniaStatus unknownNCT04359966Not applicable
• The Clinical Evaluation of Probiotics Product in Patients With Various Functional Bowel Disorders and Helicobacter Pylori InfectionStatus unknownNCT04319991Not applicable
• The Status of Helicobacter Pylori Infection Among Children Visiting Assiut Children HospitalStatus unknownNCT04212585
• Non-invasive Test-guided Tailored Therapy Versus Empiric Treatment for Helicobacter Pylori Infection.Status unknownNCT04107194Phase 3
• Effectiveness of GastimunHp Plus in Supporting the Treatment of Peptic Ulcer Disease With Helicobacter Pylori InfectionTerminatedNCT04025983Not applicable
• Empirical vs Tailored Therapy for H. Pylori InfectionStatus unknownNCT04006340Not applicable
• Assesment of the Efficiency and Safety Helicobacter Pylori Therapy With or Without Saccharomyces BoulardiiStatus unknownNCT03997279Phase 4

← Helicobacter Infections overview